Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 4
2021 6
2022 3
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Clinical evaluation of commercial automated SARS-CoV-2 immunoassays.
Kittel M, Muth MC, Zahn I, Roth HJ, Thiaucourt M, Gerhards C, Haselmann V, Neumaier M, Findeisen P. Kittel M, et al. Among authors: gerhards c. Int J Infect Dis. 2021 Feb;103:590-596. doi: 10.1016/j.ijid.2020.12.003. Epub 2020 Dec 9. Int J Infect Dis. 2021. PMID: 33310108 Free PMC article.
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2.
Özbay Kurt FG, Lepper A, Gerhards C, Roemer M, Lasser S, Arkhypov I, Bitsch R, Bugert P, Altevogt P, Gouttefangeas C, Neumaier M, Utikal J, Umansky V. Özbay Kurt FG, et al. Among authors: gerhards c. Front Immunol. 2022 Oct 12;13:1012526. doi: 10.3389/fimmu.2022.1012526. eCollection 2022. Front Immunol. 2022. PMID: 36311732 Free PMC article.
Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases.
Rotterdam J, Thiaucourt M, Weiss C, Schwaab J, Reiter A, Kreil S, Steiner L, Fenchel S, Popp HD, Hofmann WK, Bonatz K, Gerhards C, Neumaier M, Klein SA, Rao S, Jawhar M, Saussele S. Rotterdam J, et al. Among authors: gerhards c. Ann Hematol. 2022 Aug;101(8):1825-1834. doi: 10.1007/s00277-022-04866-z. Epub 2022 May 21. Ann Hematol. 2022. PMID: 35597847 Free PMC article.
Heterologous Vector-mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector-Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines.
Gerhards C, Thiaucourt M, Hetjens M, Haselmann V, Neumaier M, Kittel M. Gerhards C, et al. Vaccines (Basel). 2023 Mar 19;11(3):701. doi: 10.3390/vaccines11030701. Vaccines (Basel). 2023. PMID: 36992285 Free PMC article.
17 results